PUBLIC COMPANY
saveCalliditas Therapeutics AB
updated 13d ago
community read0 votes
pipeline
2
marketed
1
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 21Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Study to Evaluate Setanaxib in Patients With Alport Syndrome
- phase4Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
- phase2Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
- phase3Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE)
- phase3Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that